Upvote
Downvote
Executive Director - Oncology R & D - Early Development
Share Job
- Suggest Revision
- Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology.
- With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people.
- Oversees early-stage trials, such as global clinical development program for multiple product candidates with one or more indications; Interacts with our Discovery and Research programs for development of early clinical studies.
- Clinical Monitoring Planning : Oversees and coordinates Sponsor oversight of CRO clinical Monitoring activities, including plan for internal communication and issue escalation with Clinical Study Lead (CSL)
- Study strategy: Interacts with leaders of each function to develop study strategy; Approves project or Tlevel TM and biomarker strategy in collaboration with Translational Medicine and Clinical Pharmacology; Attends regulatory agency meetings and leads clinical strategy discussions
Active Job
Updated 2 days agoSimilar Job
Relevance
Active